From: powerallpharmacy@gmail.com 
  
 ADDERALL IR: (dextroamphetamine saccharate, amphetamine aspartate, 
 dextroamphetamine sulfate and amphetamine sulfate) Tablets 
  
 DESCRIPTION 
 A single-entity amphetamine product combining the neutral sulfate salts of 
 dextroamphetamine and amphetamine, with the dextro isomer of amphetamine 
 saccharate and d, l-amphetamine aspartate monohydrate. 
  
 Inactive Ingredients: lactitol, microcrystalline cellulose, colloidal 
 silicon 
 dioxide, magnesium stearate, and other ingredients. 
  
 Adderall IR 30 mg contain FD&C Yellow #6 as a color additive. 
  
 INDICATIONS 
 Adderall IR is indicated for the treatment of Attention Deficit 
 Hyperactivity 
 Disorder (ADHD) and Narcolepsy. 
  
 Attention Deficit Hyperactivity Disorder (ADHD) 
 A diagnosis of Attention Deficit Hyperactivity Disorder (ADHD; DSM-IV€€) 
 implies the presence of hyperactive-impulsive or inattentive symptoms that 
 caused impairment and were present before age 7 years. The symptoms must 
 cause 
 clinically significant 
 impairment, e.g., in social, academic, or occupational functioning, and be 
 present in two or more settings, e.g., school (or work) and at home. The 
 symptoms must not be better accounted for by another mental disorder. For 
 the 
 Inattentive Type, at least 
 six of the following symptoms must have persisted for at least 6 months: 
 lack 
 of attention to details/careless mistakes; lack of sustained attention; poor 
 listener; failure to follow through on tasks; poor organization; avoids 
 tasks 
 requiring sustained 
 mental effort; loses things; easily distracted; forgetful. For the 
 Hyperactive-Impulsive Type, at least six of the following symptoms must have 
 persisted for at least 6 months: fidgeting/squirming; leaving seat; 
 inappropriate running/climbing; difficulty 
 with quiet activities; €€€on the go;€€€ excessive talking; blurting answers; 
 can't wait turn; intrusive. The Combined Type requires both inattentive and 
 hyperactive-impulsive criteria to be met. 
  
 DOSAGE AND ADMINISTRATION 
 Regardless of indication, amphetamines should be administered at the lowest 
 effective dosage, and dosage should be individually adjusted according to 
 the 
 therapeutic needs and response of the patient. Late evening doses should be 
 avoided because of the 
 resulting insomnia. 
  
 Attention Deficit Hyperactivity Disorder 
 Not recommended for children under 3 years of age. In children from 3 to 5 
 years of age, start with 2.5 mg daily; daily dosage may be raised in 
 increments of 2.5 mg at weekly intervals until optimal response is obtained. 
  
 In children 6 years of age and older, start with 5 mg once or twice daily; 
 daily dosage may be raised in increments of 5 mg at weekly intervals until 
 optimal response is obtained. Only in rare cases will it be necessary to 
 exceed a total of 40 mg per day. 
  Give first dose on awakening; additional doses (1 or 2) at intervals of 4 
 to 
 6 hours. 
  
 Where possible, drug administration should be interrupted occasionally to 
 determine if there is a recurrence of behavioral symptoms sufficient to 
 require continued therapy. 
  
 Adderall IR 30 mg: A round, flat-faced beveled edge, orange tablet, €€€30€€€ 
 embossed on one side with a full and partial bisect and €€€AD€€€ embossed on 
 the other side, supplied as follows: 
  
 100 Tablets Unit-of-use NDC 0555-0768-02 
  
 Dispense in a tight, light-resistant container. 
  
 Store at 20€€ to 25€€C (68€€ to 77€€F) [See USP Controlled Room 
 Temperature]. 
  
 For More Details: 
 https://www.powerallpharmacy.ca/index.php?main_page=product_info 
 cPath=1_9&products_id=177 
 Whatsapp: +1 (336) 267-4575 
  
 --- SoupGate-Win32 v1.05 
  * Origin: you cannot sedate... all the things you hate (1:229/2)